ReP USP - Resultado da busca

Artigo de periodico
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol (2021)
Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Los, Bruna; Barbosa, Thais Kristini Almendros Afonso; Marçal, Elisangela da Silva Rodrigues; Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Mori, Augusto Akira ; Hirata, Thiago Dominguez Crespo ; Nakaya, Helder Takashi Imoto ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Gonçalves, Rodrigo Marques; Araújo, Daniel Branco de; Zatz, Henry Paulo; Bertolami, Adriana; Faludi, André Arpad; Bertolami, Marcelo Chiara ; Sousa, Amanda Guerra de Moraes Rego ; França, Joao Italo Dias ; Jannes, Cinthia Elim; Pereira, Alexandre da Costa; Nakazone, Marcelo Arruda; Souza, Dorotéia Rossi Silva; Carmo, Tayanne Silva; Sampaio, Marcelo Ferraz; Gorjão, Renata ; Curi, Tania Cristina Pithon ; Moriel, Patricia; Silbiger, Vivian Nogueira ; Luchessi, André Ducati ; Araújo, Jéssica Nayara Góes de; Naslavsky, Michel ; Wang, Jaqueline Yu Ting; Kronenberger, Thales ; Cerda, Alvaro ; Wang, Hui Tzu Lin; Garofalo, Adriana Regina; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Research in Social and Administrative Pharmacy. Unidades: FCF, IDPC, FM, IB
Subjects: GENÔMICA, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, EXONS, LINFÓCITOS, LINHAGEM CELULAR, MUTAGÊNESE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, v. 17, n. 7, p. 1347-1355, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2020.10.007. Acesso em: 25 set. 2024.
APA
Borges, J. B., Oliveira, V. F. de, Ferreira, G. M., Los, B., Barbosa, T. K. A. A., Marçal, E. da S. R., et al. (2021). Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, 17( 7), 1347-1355. doi:10.1016/j.sapharm.2020.10.007
NLM
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Vancouver
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Artigo de periodico
Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study (2015)
Zambrano, Tomás; Hirata, Mario Hiroyuki ; Cerda, Alvaro; Dórea, Egidio Lima; Pinto, Gelba Almeida; Gusukuma, Maria Cecília; Bertolami, Marcelo Chiara; Salazar, Luís Antônio; Hirata, Rosario Dominguez Crespo
Source: International Journal of Clinical and Experimental Medicine. Unidades: FCF, HU
Subjects: COLESTEROL, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAMBRANO, Tomás et al. Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study. International Journal of Clinical and Experimental Medicine, v. 8, n. 4, p. 5978-5988, 2015Tradução . . Disponível em: http://www.ijcem.com/files/ijcem0006450.pdf. Acesso em: 25 set. 2024.
APA
Zambrano, T., Hirata, M. H., Cerda, A., Dórea, E. L., Pinto, G. A., Gusukuma, M. C., et al. (2015). Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study. International Journal of Clinical and Experimental Medicine, 8( 4), 5978-5988. Recuperado de http://www.ijcem.com/files/ijcem0006450.pdf
NLM
Zambrano T, Hirata MH, Cerda A, Dórea EL, Pinto GA, Gusukuma MC, Bertolami MC, Salazar LA, Hirata RDC. Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study [Internet]. International Journal of Clinical and Experimental Medicine. 2015 ; 8( 4): 5978-5988.[citado 2024 set. 25 ] Available from: http://www.ijcem.com/files/ijcem0006450.pdf
Vancouver
Zambrano T, Hirata MH, Cerda A, Dórea EL, Pinto GA, Gusukuma MC, Bertolami MC, Salazar LA, Hirata RDC. Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study [Internet]. International Journal of Clinical and Experimental Medicine. 2015 ; 8( 4): 5978-5988.[citado 2024 set. 25 ] Available from: http://www.ijcem.com/files/ijcem0006450.pdf
Artigo de periodico
Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects (2014)
Anderson, Jacqueline M.; Cerda, Alvaro ; Hirata, Mario Hiroyuki ; Rodrigues, Alice Cristina ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Bertolami, Marcelo Chiara ; Faludi, André Arpad; Hirata, Rosario Dominguez Crespo
Source: Journal of Clinical Lipidology. Unidades: FCF, ICB, HU
Subjects: POLIMORFISMO, COLESTEROL, FARMACOLOGIA, LIPÍDEOS, NUCLEOTÍDEOS, FARMACOGENÉTICA, LIPOPROTEÍNAS LDL, REAÇÃO EM CADEIA POR POLIMERASE, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDERSON, Jacqueline M. et al. Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects. Journal of Clinical Lipidology, v. 8, n. 3, p. 256-264, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.jacl.2014.02.008. Acesso em: 25 set. 2024.
APA
Anderson, J. M., Cerda, A., Hirata, M. H., Rodrigues, A. C., Dórea, E. L., Bernik, M. M. S., et al. (2014). Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects. Journal of Clinical Lipidology, 8( 3), 256-264. doi:10.1016/j.jacl.2014.02.008
NLM
Anderson JM, Cerda A, Hirata MH, Rodrigues AC, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Hirata RDC. Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects [Internet]. Journal of Clinical Lipidology. 2014 ; 8( 3): 256-264.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.jacl.2014.02.008
Vancouver
Anderson JM, Cerda A, Hirata MH, Rodrigues AC, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Hirata RDC. Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects [Internet]. Journal of Clinical Lipidology. 2014 ; 8( 3): 256-264.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.jacl.2014.02.008
Artigo de periodico
Atorvastatin and hormone therapy influence expression of ABCA1, APOA1 and SCARB1 in mononuclear cells from hypercholesterolemic postmenopausal women (2013)
Cerda, Alvaro; Issa, Mustafa Hassan; Genvigir, Fabiana Dalla Vecchia; Rohde, Cíntia Blujus; Cavalli, Selma Andrea; Bertolami, Marcelo Chiara; Faludi, André Arpad; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Journal of Steroid Biochemistry and Molecular Biology. Unidade: FCF
Subjects: MENOPAUSA, HIPERCOLESTEROLEMIA, TERAPIA DA REPOSIÇÃO HORMONAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Atorvastatin and hormone therapy influence expression of ABCA1, APOA1 and SCARB1 in mononuclear cells from hypercholesterolemic postmenopausal women. Journal of Steroid Biochemistry and Molecular Biology, v. 138, p. 403-409, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.jsbmb.2013.08.017. Acesso em: 25 set. 2024.
APA
Cerda, A., Issa, M. H., Genvigir, F. D. V., Rohde, C. B., Cavalli, S. A., Bertolami, M. C., et al. (2013). Atorvastatin and hormone therapy influence expression of ABCA1, APOA1 and SCARB1 in mononuclear cells from hypercholesterolemic postmenopausal women. Journal of Steroid Biochemistry and Molecular Biology, 138, 403-409. doi:10.1016/j.jsbmb.2013.08.017
NLM
Cerda A, Issa MH, Genvigir FDV, Rohde CB, Cavalli SA, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Atorvastatin and hormone therapy influence expression of ABCA1, APOA1 and SCARB1 in mononuclear cells from hypercholesterolemic postmenopausal women [Internet]. Journal of Steroid Biochemistry and Molecular Biology. 2013 ; 138 403-409.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.jsbmb.2013.08.017
Vancouver
Cerda A, Issa MH, Genvigir FDV, Rohde CB, Cavalli SA, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Atorvastatin and hormone therapy influence expression of ABCA1, APOA1 and SCARB1 in mononuclear cells from hypercholesterolemic postmenopausal women [Internet]. Journal of Steroid Biochemistry and Molecular Biology. 2013 ; 138 403-409.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.jsbmb.2013.08.017
Artigo de periodico
Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients (2013)
Willrich, Maria Alice Vieira; Rodrigues, Alice Cristina ; Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Arazi, Simone Sorkin; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Bertolami, Marcelo Chiara; Faludi, André Arpad; Largura, Alvaro; Baudhuin, Linnea M; Bryant, Sandra C; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Clinica Chimica Acta. Unidades: HU, FCF
Subjects: EXPRESSÃO GÊNICA, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLRICH, Maria Alice Vieira et al. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients. Clinica Chimica Acta, v. 421, p. 157-163, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2013.03.007. Acesso em: 25 set. 2024.
APA
Willrich, M. A. V., Rodrigues, A. C., Cerda, A., Genvigir, F. D. V., Arazi, S. S., Dórea, E. L., et al. (2013). Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients. Clinica Chimica Acta, 421, 157-163. doi:10.1016/j.cca.2013.03.007
NLM
Willrich MAV, Rodrigues AC, Cerda A, Genvigir FDV, Arazi SS, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Largura A, Baudhuin LM, Bryant SC, Hirata MH, Hirata RDC. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients [Internet]. Clinica Chimica Acta. 2013 ; 421 157-163.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.cca.2013.03.007
Vancouver
Willrich MAV, Rodrigues AC, Cerda A, Genvigir FDV, Arazi SS, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Largura A, Baudhuin LM, Bryant SC, Hirata MH, Hirata RDC. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients [Internet]. Clinica Chimica Acta. 2013 ; 421 157-163.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.cca.2013.03.007
Artigo de periodico
Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population (2012)
Silbiger, Vivian Nogueira; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Genvigir, Fabiana Dalla Vecchia; Cerda, Alvaro; Rodrigues, Alice Cristina ; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Faludi, André Arpad; Bertolami, Marcelo Chiara; Santos, Carla; Carracedo, Ángel; Salas, Antonio; Freire, Ana; Lareu, Maria Victoria; Phillips, Christopher; Porras-Hurtado, Liliana; Fondevilla, Manuel; Hirata, Rosario Dominguez Crespo
Source: Genetic Testing and Molecular Biomarkers. Unidades: FCF, HU
Subjects: POLIMORFISMO, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILBIGER, Vivian Nogueira et al. Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population. Genetic Testing and Molecular Biomarkers, v. 16, n. 6, p. 524-530, 2012Tradução . . Disponível em: https://doi.org/10.1089/gtmb.2011.0267. Acesso em: 25 set. 2024.
APA
Silbiger, V. N., Hirata, M. H., Luchessi, A. D., Genvigir, F. D. V., Cerda, A., Rodrigues, A. C., et al. (2012). Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population. Genetic Testing and Molecular Biomarkers, 16( 6), 524-530. doi:10.1089/gtmb.2011.0267
NLM
Silbiger VN, Hirata MH, Luchessi AD, Genvigir FDV, Cerda A, Rodrigues AC, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Faludi AA, Bertolami MC, Santos C, Carracedo Á, Salas A, Freire A, Lareu MV, Phillips C, Porras-Hurtado L, Fondevilla M, Hirata RDC. Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population [Internet]. Genetic Testing and Molecular Biomarkers. 2012 ; 16( 6): 524-530.[citado 2024 set. 25 ] Available from: https://doi.org/10.1089/gtmb.2011.0267
Vancouver
Silbiger VN, Hirata MH, Luchessi AD, Genvigir FDV, Cerda A, Rodrigues AC, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Faludi AA, Bertolami MC, Santos C, Carracedo Á, Salas A, Freire A, Lareu MV, Phillips C, Porras-Hurtado L, Fondevilla M, Hirata RDC. Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population [Internet]. Genetic Testing and Molecular Biomarkers. 2012 ; 16( 6): 524-530.[citado 2024 set. 25 ] Available from: https://doi.org/10.1089/gtmb.2011.0267
Artigo de periodico
Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women (2012)
Issa, Mustafa Hassan; Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Cavalli, Selma Andrea; Bertolami, Marcelo Chiara; Faludi, André Arpad; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Journal of Steroid Biochemistry and Molecular Biology. Unidade: FCF
Subjects: MENOPAUSA, APOLIPOPROTEÍNAS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ISSA, Mustafa Hassan et al. Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women. Journal of Steroid Biochemistry and Molecular Biology, v. 128, n. 3-5, p. 139-144, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.jsbmb.2011.11-001. Acesso em: 25 set. 2024.
APA
Issa, M. H., Cerda, A., Genvigir, F. D. V., Cavalli, S. A., Bertolami, M. C., Faludi, A. A., et al. (2012). Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women. Journal of Steroid Biochemistry and Molecular Biology, 128( 3-5), 139-144. doi:10.1016/j.jsbmb.2011.11-001
NLM
Issa MH, Cerda A, Genvigir FDV, Cavalli SA, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women [Internet]. Journal of Steroid Biochemistry and Molecular Biology. 2012 ; 128( 3-5): 139-144.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.jsbmb.2011.11-001
Vancouver
Issa MH, Cerda A, Genvigir FDV, Cavalli SA, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women [Internet]. Journal of Steroid Biochemistry and Molecular Biology. 2012 ; 128( 3-5): 139-144.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.jsbmb.2011.11-001
Trabalho de evento-resumo periodico
Atorvastatin and hormone replacement therapy affect expression of genes regulating the reverse cholesterol transport in mononuclear cells from postmenopausal women (2011)
Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Rohde, Ciro B. S; Issa, M; Cavalli, Selma Andrea; Bertolami, Marcelo Chiara; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Atherosclerosis Supplements. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Subjects: TERAPIA DE REPOSIÇÃO DE ESTRÓGENOS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Atorvastatin and hormone replacement therapy affect expression of genes regulating the reverse cholesterol transport in mononuclear cells from postmenopausal women. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 25 set. 2024. , 2011
APA
Cerda, A., Genvigir, F. D. V., Rohde, C. B. S., Issa, M., Cavalli, S. A., Bertolami, M. C., et al. (2011). Atorvastatin and hormone replacement therapy affect expression of genes regulating the reverse cholesterol transport in mononuclear cells from postmenopausal women. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Cerda A, Genvigir FDV, Rohde CBS, Issa M, Cavalli SA, Bertolami MC, Hirata MH, Hirata RDC. Atorvastatin and hormone replacement therapy affect expression of genes regulating the reverse cholesterol transport in mononuclear cells from postmenopausal women. Atherosclerosis Supplements. 2011 ; 12( 1): 45 res. 201.[citado 2024 set. 25 ]
Vancouver
Cerda A, Genvigir FDV, Rohde CBS, Issa M, Cavalli SA, Bertolami MC, Hirata MH, Hirata RDC. Atorvastatin and hormone replacement therapy affect expression of genes regulating the reverse cholesterol transport in mononuclear cells from postmenopausal women. Atherosclerosis Supplements. 2011 ; 12( 1): 45 res. 201.[citado 2024 set. 25 ]
Artigo de periodico
Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin (2011)
Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Bernik, Marcia Martins Silveira; Dórea, Egidio Lima; Bertolami, Marcelo Chiara; Faludi, André Arpad; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Lipids in Health and Disease. Unidades: FCF, HU
Subjects: APOLIPOPROTEÍNAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin. Lipids in Health and Disease, v. 10, p. 1-11, 2011Tradução . . Disponível em: https://doi.org/10.1186/1476-511X-10-206. Acesso em: 25 set. 2024.
APA
Cerda, A., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Bernik, M. M. S., Dórea, E. L., et al. (2011). Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin. Lipids in Health and Disease, 10, 1-11. doi:10.1186/1476-511X-10-206
NLM
Cerda A, Genvigir FDV, Willrich MAV, Arazi SS, Bernik MMS, Dórea EL, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin [Internet]. Lipids in Health and Disease. 2011 ; 10 1-11.[citado 2024 set. 25 ] Available from: https://doi.org/10.1186/1476-511X-10-206
Vancouver
Cerda A, Genvigir FDV, Willrich MAV, Arazi SS, Bernik MMS, Dórea EL, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin [Internet]. Lipids in Health and Disease. 2011 ; 10 1-11.[citado 2024 set. 25 ] Available from: https://doi.org/10.1186/1476-511X-10-206
Trabalho de evento-resumo periodico
Atorvastatin down-regulates APOE mRNA expression in postmenopausal women (2010)
Issa, Mustafa Hassan; Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Cavalli, Selma Andrea; Bertolami, Marcelo Chiara; Faludi, André Arpad; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry and Laboratory Medicine. Conference titles: Santorini Conference Biologie Prospective. Unidade: FCF
Subjects: PÓS-MENOPAUSA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ISSA, Mustafa Hassan et al. Atorvastatin down-regulates APOE mRNA expression in postmenopausal women. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 25 set. 2024. , 2010
APA
Issa, M. H., Cerda, A., Genvigir, F. D. V., Cavalli, S. A., Bertolami, M. C., Faludi, A. A., et al. (2010). Atorvastatin down-regulates APOE mRNA expression in postmenopausal women. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Issa MH, Cerda A, Genvigir FDV, Cavalli SA, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Atorvastatin down-regulates APOE mRNA expression in postmenopausal women. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A68 res. B15.[citado 2024 set. 25 ]
Vancouver
Issa MH, Cerda A, Genvigir FDV, Cavalli SA, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Atorvastatin down-regulates APOE mRNA expression in postmenopausal women. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A68 res. B15.[citado 2024 set. 25 ]

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Indexado em

Non normalized affiliation